CUBIST PHARMACEUTICALS INC Financing Cash Flow
CUBIST PHARMACEUTICALS INC reported Financing Cash Flow of $37.81 million for the 6-month period ending 2011-06-30, per its 10-Q filed 2011-07-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2011-07-29
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-06-30 was $27.15M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-03-31 was $10.66M, a 46.39% decline year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2010-12-31 was $239.91M, a 45860.73% increase year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2010-09-30 was $4.46M, a 65.28% increase year-over-year.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was $252.99M, a 4981.08% increase from fiscal 2009.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2009 was $4.98M.
- CUBIST PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2008 was -$32.42M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2011-06-30 | $27.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | $37.81M 10-Q · filed 2011-07-29 | $277.73M derived: sum of 3 quarters · filed 2011-07-29 | $282.19M derived: sum of 4 quarters · filed 2011-07-29 |
| 2011-03-31 | $10.66M 10-Q · filed 2011-04-29 | $250.58M derived: sum of 2 quarters · filed 2011-04-29 | $255.04M derived: sum of 3 quarters · filed 2011-04-29 | $243.76M derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-12-31 | $239.91M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-23 | $244.38M derived: sum of 2 quarters · filed 2011-02-23 | $233.10M derived: sum of 3 quarters · filed 2011-07-29 | $252.99M 10-K · filed 2011-02-23 |
| 2010-09-30 | $4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | -$6.82M derived: sum of 2 quarters · filed 2011-07-29 | $13.07M 10-Q · filed 2010-10-29 | $13.59M derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-06-30 | -$11.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | $8.61M 10-Q · filed 2011-07-29 | $9.13M derived: sum of 3 quarters · filed 2011-07-29 | $11.83M derived: sum of 4 quarters · filed 2011-07-29 |
| 2010-03-31 | $19.89M 10-Q · filed 2011-04-29 | $20.41M derived: sum of 2 quarters · filed 2011-04-29 | $23.11M derived: sum of 3 quarters · filed 2011-04-29 | |
| 2009-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-23 | $3.22M derived: sum of 2 quarters · filed 2011-02-23 | $4.98M 10-K · filed 2011-02-23 | |
| 2009-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $4.46M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $1.76M 10-Q · filed 2010-07-30 | |||
| 2008-12-31 | -$32.42M 10-K · filed 2011-02-23 |